Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.

Abstract

OBJECTIVE:

To investigate the effects of Tongluo Digui decoction on renal injury and streptozotocin-induced podocyte autophagy in diabetic rats.

METHODS:

Male Sprague-Dawley rats were randomly divided into six groups: normal, model, Tongluo Digui decoction (high, medium, and low dose) and valsartan. Streptozotocin was injected intraperitoneally to replicate the diabetic animal model. After 8 weeks, proteinuria was evaluated to establish the diabetic nephropathy model. Treatments were administered daily via the intragastric route. At 16 weeks after gavage, we determined 24 h urine protein concentration, and blood glucose, serum creatinine, and urea nitrogen concentrations. Then, rats were sacrificed, and kidneys were harvested and stained with periodic acid-Schiff to evaluate the pathological changes in glomeruli, including glomerular podocytes by transmission electron microscopy. Western blot analysis was used to determine the expression of nephrin, podocin, p62, beclin-1, LC3Ⅱ/Ⅰ, and p-mTOR/mTOR protein in kidney tissues.

RESULTS:

Compared with the model group, Tongluo Digui decoction was associated with decreases in 24 h urine protein concentration, and blood glucose, hemoglobin A1c, serum creatinine, urea nitrogen concentrations, total serum protein and albumin. Concurrently, mesangial mesenteric broadening and fusion of foot processes were reduced, the glomerular basement membrane was not significantly thickened, and the number of podocytes and the number of autophagosomes in the podocytes was increased. Further, expression of nephrin, podocin, LC3Ⅱ, and beclin-1 protein in kidney tissue was up-regulated, while expression of p62 protein was down-regulated and mTOR phosphorylation was inhibited.

CONCLUSION:

Tongluo Digui decoction may inhibit the progression of diabetic nephropathy by inhibiting mTOR phosphorylation, thereby increasing autophagy to protect podocytes and reducing proteinuria.

• Authors: Jiarui Han, Yage Zhang, Xiujie Shi, Zining Peng, Yufeng Xing, Xinxin Pang
• Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan (J Tradit Chin Med) Vol. 41 Issue 1 Pg. 125-132 (02 2021) ISSN: 2589-451X [Electronic] China
• PMID: 33522205 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Drugs, Chinese Herbal
• Intracellular Signaling Peptides and Proteins
• Membrane Proteins
• NPHS2 protein
• nephrin
• tongluo
• TOR Serine-Threonine Kinases

Topics

• Animals
• Autophagy (drug effects)
• Diabetic Nephropathies (drug therapy, genetics, metabolism, physiopathology)
• Disease Models, Animal
• Drugs, Chinese Herbal (administration & dosage)
• Humans
• Intracellular Signaling Peptides and Proteins (genetics, metabolism)
• Kidney (cytology, drug effects, injuries, metabolism)
• Male
• Membrane Proteins (genetics, metabolism)
• Podocytes (cytology, drug effects)
• Rats
• Rats, Sprague-Dawley
• TOR Serine-Threonine Kinases (genetics, metabolism)